L. E. Eckardt
#153,622
Most Influential Person Now
L. E. Eckardt's AcademicInfluence.com Rankings
L. E. Eckardtengineering Degrees
Engineering
#6315
World Rank
#7632
Historical Rank
Biomedical Engineering
#551
World Rank
#561
Historical Rank
L. E. Eckardtphilosophy Degrees
Philosophy
#8598
World Rank
#12008
Historical Rank
Logic
#5631
World Rank
#7043
Historical Rank
Download Badge
Engineering Philosophy
Why Is L. E. Eckardt Influential?
(Suggest an Edit or Addition)L. E. Eckardt's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry (2010) (746)
- Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. (2020) (626)
- Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial (2010) (617)
- Long-Term Prognosis of Individuals With Right Precordial ST-Segment–Elevation Brugada Syndrome (2005) (429)
- Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial (2019) (401)
- Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. (2002) (374)
- Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study. (2017) (244)
- Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de Pointes (2002) (238)
- Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial (2002) (237)
- Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: Different incidences in familial and sporadic disease (2003) (230)
- Catheter Ablation of Ventricular Tachycardia (2009) (218)
- Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation: Results From the Gap-Atrial Fibrillation–German Atrial Fibrillation Competence Network 1 Trial (2016) (197)
- A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. (2006) (180)
- Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. (2007) (177)
- The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol. (2003) (176)
- 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. (2022) (175)
- Cardiac Autonomic Dysfunction in Brugada Syndrome (2002) (175)
- Occult Atrial Fibrillation in Cryptogenic Stroke: Detection by 7-Day Electrocardiogram Versus Implantable Cardiac Monitors (2013) (160)
- Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. (2019) (160)
- Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. (2013) (154)
- Brugada Syndrome and Supraventricular Tachyarrhythmias: A Novel Association? (2001) (153)
- Experimental models of torsade de pointes. (1998) (144)
- Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms (2016) (115)
- Prolonged Atrial Action Potential Durations and Polymorphic Atrial Tachyarrhythmias in Patients with Long QT Syndrome (2003) (113)
- Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. (2002) (112)
- Inhibition of the Na+/Ca2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3. (2008) (100)
- Abnormal Myocardial Presynaptic Norepinephrine Recycling in Patients With Brugada Syndrome (2004) (99)
- Echocardiographic assessment of global left ventricular function in mice (2009) (98)
- Damage to the Esophagus After Atrial Fibrillation Ablation: Just the Tip of the Iceberg? High Prevalence of Mediastinal Changes Diagnosed by Endosonography (2010) (92)
- Predictors of Atrial Fibrillation Recurrence after Catheter Ablation: Data from the German Ablation Registry (2017) (92)
- Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up. (2005) (92)
- Reduction of Dispersion of Repolarization and Prolongation of Postrepolarization Refractoriness Explain the Antiarrhythmic Effects of Quinidine in a Model of Short QT Syndrome (2007) (90)
- Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation. (2002) (87)
- Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3. (2005) (87)
- Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF PCI trial (2018) (86)
- Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. (2013) (81)
- Shock Efficacy of Subcutaneous Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac Death: Initial Multicenter Experience (2012) (81)
- A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA). (2005) (80)
- Incidence, characteristics, and outcome of left atrial tachycardias after circumferential antral ablation of atrial fibrillation. (2012) (79)
- Comparison of the In Vitro Electrophysiologic and Proarrhythmic Effects of Amiodarone and Sotalol in a Rabbit Model of Acute Atrioventricular Block (2004) (77)
- Randomized study comparing duty-cycled bipolar and unipolar radiofrequency with point-by-point ablation in pulmonary vein isolation. (2011) (76)
- Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia (2003) (76)
- Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes (2000) (72)
- Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome. (2005) (72)
- Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT) (2020) (68)
- Sex-related outcome of atrial fibrillation ablation: Insights from the German Ablation Registry. (2016) (67)
- Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry (2017) (67)
- Supraventricular Premature Beats and Short Atrial Runs Predict Atrial Fibrillation in Continuously Monitored Patients With Cryptogenic Stroke (2014) (66)
- Body Surface Area of ST Elevation and the Presence of Late Potentials Correlate to the Inducibility of Ventricular Tachyarrhythmias in Brugada Syndrome (2002) (65)
- Risk stratification in arrhythmogenic right ventricular cardiomyopathy (2013) (65)
- Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure (2021) (64)
- Electrocardiographic risk stratification in families with congenital long QT syndrome. (2006) (64)
- Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation (2019) (63)
- Endocardial Mapping of Right Ventricular Outflow Tract Tachycardia Using Noncontact Activation Mapping (2003) (63)
- Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin. (1998) (63)
- Proarrhythmia as a Class Effect of Quinolones: Increased Dispersion of Repolarization and Triangulation of Action Potential Predict Torsades de Pointes (2007) (63)
- Prophylactic proton pump inhibition after atrial fibrillation ablation: is there any evidence? (2011) (63)
- Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome. (2002) (62)
- Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3 (2005) (59)
- Bradiarritmias y bloqueos de la conducción (2012) (59)
- Arrhythmogenic Right Ventricular Cardiomyopathy (2005) (59)
- A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase‐III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing‐induced heart failure (2011) (59)
- Absence of Pathognomonic or Inflammatory Patterns in Cardiac Biopsies From Patients With Brugada Syndrome (2008) (58)
- LAMP-2 deficient mice show depressed cardiac contractile function without significant changes in calcium handling (2006) (57)
- Comparison of a Novel, Single-Lead Atrial Sensing System With a Dual-Chamber Implantable Cardioverter-Defibrillator System in Patients Without Antibradycardia Pacing Indications: Results of a Randomized Study (2011) (56)
- New formula for evaluation of the QT interval in patients with left bundle branch block. (2014) (56)
- Doppler echocardiography and tissue Doppler imaging in the healthy rabbit: differences of cardiac function during awake and anaesthetised examination. (2007) (55)
- Amiodarone-Induced Postrepolarization Refractoriness Suppresses Induction of Ventricular Fibrillation (2003) (54)
- Predisposing factors for atrial fibrillation in the elderly (2017) (54)
- Electrocardiographic changes during therapeutic hypothermia. (2012) (54)
- Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review (2018) (53)
- Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study. (2009) (53)
- Transcriptional profiling of ion channel genes in Brugada syndrome and other right ventricular arrhythmogenic diseases. (2009) (53)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population (2020) (53)
- Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure (2012) (51)
- Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation (2019) (50)
- Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure: incremental prognostic value of QRS duration and a restrictive mitral filling pattern. (2005) (49)
- Effects of Thoracic Epidural Anesthesia with and without Autonomic Nervous System Blockade on Cardiac Monophasic Action Potentials and Effective Refractoriness in Awake Dogs (2001) (47)
- Prevalence of Supraventricular Tachyarrhythmias in a Cohort of 115 Patients with Brugada Syndrome (2008) (46)
- Bradyarrhythmias and conduction blocks. (2012) (45)
- Cardiac Sympathetic Dysfunction in Genotyped Patients with Arrhythmogenic Right Ventricular Cardiomyopathy and Risk of Recurrent Ventricular Tachyarrhythmias (2011) (45)
- Tpeak-Tend interval and Tpeak-Tend/QT ratio in patients with Brugada syndrome. (2016) (44)
- Dual atrioventricular nodal non-re-entrant tachycardia. (2016) (43)
- Arrhythmias in Heart Failure: (2000) (43)
- Triple threat: the Na+/Ca2+ exchanger in the pathophysiology of cardiac arrhythmia, ischemia and heart failure. (2011) (42)
- Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure. (2012) (42)
- Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers (2006) (40)
- Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial (2021) (40)
- Age and gender related reference values for transthoracic Doppler-echocardiography in the anesthetized CD1 mouse (2006) (40)
- Fatal course of esophageal stenting of an atrioesophageal fistula after atrial fibrillation ablation. (2011) (40)
- Ablation of atrioventricular nodal reentrant tachycardia in the elderly: results from the German Ablation Registry. (2011) (40)
- Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry (2013) (40)
- A novel nonfluoroscopic catheter visualization system (LocaLisa) to reduce radiation exposure during catheter ablation of supraventricular tachycardias. (2002) (40)
- Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness. (2013) (39)
- Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry (2015) (38)
- Antiarrhythmic effects of free polyunsaturated fatty acids in an experimental model of LQT2 and LQT3 due to suppression of early afterdepolarizations and reduction of spatial and temporal dispersion of repolarization. (2011) (37)
- Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature. (2011) (36)
- Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits. (2012) (36)
- Modification of stretch-induced shortening of repolarization by streptomycin in the isolated rabbit heart. (2000) (36)
- Proarrhythmia in a non-failing murine model of cardiac-specific Na+/Ca2+ exchanger overexpression: whole heart and cellular mechanisms (2012) (36)
- Load-induced changes in repolarization: evidence from experimental and clinical data (2001) (36)
- Body surface potential mapping in patients with Brugada syndrome: right precordial ST segment variations and reverse changes in left precordial leads. (2002) (35)
- New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia. (2012) (35)
- Gender Differences in Brugada Syndrome (2007) (35)
- Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience (2015) (35)
- Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents (2011) (35)
- The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial. (2015) (34)
- Prospective blinded Evaluation of the smartphone-based AliveCor Kardia ECG monitor for Atrial Fibrillation detection: The PEAK-AF study. (2019) (34)
- Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repair. (2013) (34)
- The ECG in cardiovascular-relevant animal models of electrophysiology (2013) (33)
- Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole‐Heart Model of Short QT Syndrome (2016) (33)
- Pulmonary vein variants predispose to atrial fibrillation: a case-control study using multislice contrast-enhanced computed tomography. (2011) (32)
- Wolff‐Parkinson‐White Syndrome Associated with Brugada Syndrome (2001) (32)
- Transient Local Changes in Right Ventricular Monophasic Action Potentials Due to Ajmaline in a Patient with Brugada Syndrome (1999) (32)
- Cervical intramedullar schistosomiasis as a rare cause of acute tetraparesis (2001) (31)
- Idiopathic ventricular outflow tract arrhythmias from the great cardiac vein: challenges and risks of catheter ablation. (2013) (31)
- Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation. (2013) (31)
- Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems (2017) (31)
- Updated Survey on Interventional Electrophysiology: 5-Year Follow-Up of Infrastructure, Procedures, and Training Positions in Germany. (2018) (31)
- Modified phased radiofrequency ablation of atrial fibrillation reduces the number of cerebral microembolic signals. (2014) (30)
- Phytanic Acid Accumulation Is Associated with Conduction Delay and Sudden Cardiac Death in Sterol Carrier Protein‐2/Sterol Carrier Protein‐x Deficient Mice (2004) (30)
- A Patient with “Atrial Torsades de Pointes” (2000) (30)
- Suppression of Early and Late Afterdepolarizations by Heterozygous Knockout of the Na+/Ca2+ Exchanger in a Murine Model (2015) (30)
- By Regulating Mitochondrial Ca2+-Uptake UCP2 Modulates Intracellular Ca2+ (2016) (29)
- Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up. (2012) (29)
- Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. (2020) (29)
- Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines. (2011) (28)
- Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue? (2016) (28)
- Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease. (2015) (28)
- Ventricular arrhythmias from the mitral annulus: patient characteristics, electrophysiological findings, ablation, and prognosis. (2013) (28)
- A survey of German centres performing invasive electrophysiology: structure, procedures, and training positions. (2013) (28)
- Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults. (2017) (28)
- Morbidity and treatment in patients with atrial fibrillation and chronic kidney disease. (2015) (28)
- Blockade of ICa suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failure (2012) (28)
- Panic attacks and supraventricular tachycardias: the chicken or the egg? (2013) (28)
- Fetoscopic transesophageal electrocardiography and stimulation in fetal sheep: a minimally invasive approach aimed at diagnosis and termination of therapy-refractory supraventricular tachycardias in human fetuses. (1999) (27)
- Diastolic isthmus length and 'vertical' isthmus angulation identify patients with difficult catheter ablation of typical atrial flutter: a pre-procedural MRI study. (2008) (27)
- Electrophysiologic Profile of Dronedarone on the Ventricular Level: Beneficial Effect on Postrepolarization Refractoriness in the Presence of Rapid Phase 3 Repolarization (2012) (27)
- Primary prevention of sudden cardiac death (2006) (27)
- Molecular Mechanisms of Inherited Ventricular Arrhythmias (2002) (27)
- A Heterozygous Deletion Mutation in the Cardiac Sodium Channel Gene SCN5A with Loss- and Gain-of-Function Characteristics Manifests as Isolated Conduction Disease, without Signs of Brugada or Long QT Syndrome (2013) (26)
- Comparison of outcomes in patients with insulin-dependent versus non-insulin dependent diabetes mellitus receiving drug-eluting stents (from the first phase of the prospective multicenter German DES.DE registry). (2010) (26)
- Safety and efficacy in ablation of premature ventricular contraction: data from the German ablation registry (2016) (26)
- Divergent Effect of Acute Ventricular Dilatation on the Electrophysiologic Characteristics of d,I‐Sotalol and Flecainide in the Isolated Rebbit heart (1998) (25)
- Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation (2005) (25)
- Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE—registry (2013) (25)
- Clinical aspects of ventricular arrhythmias associated with QT prolongation (2001) (25)
- T Wave Alternans Does not Assess Arrhythmic Risk in Patients with Brugada Syndrome (2004) (24)
- Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry (2010) (24)
- Catheter Ablation of Stable Ventricular Tachycardia Before Defibrillator Implantation in Patients with Coronary Heart Disease (VTACH): An On‐Treatment Analysis (2013) (24)
- Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged ≥75 Years versus <75 Years—Results from the German Ablation Registry (2017) (24)
- Pulmonary vein isolation in patients with paroxysmal atrial fibrillation is associated with regional cardiac sympathetic denervation (2013) (23)
- Interatrial Conduction Delay and Atrioventricular Block Due to Primary Cardiac Lymphoma (2005) (23)
- Further evidence of a close anatomical relation between the oesophagus and pulmonary veins. (2005) (22)
- Acute and long-term outcome of focal atrial tachycardia ablation in the real world: results of the german ablation registry (2018) (22)
- Predictors for Progression of Atrial Fibrillation in Patients Awaiting Atrial Fibrillation Ablation. (2016) (22)
- Impact of Structural Heart Disease on the Acute Complication Rate in Atrial Fibrillation Ablation: Results from the German Ablation Registry (2014) (22)
- Leitlinie invasive elektrophysiologische Diagnostik (2007) (22)
- Sertindole: cardiac electrophysiological profile (2002) (21)
- Totally Subcutaneous Implantable Cardioverter Defibrillator with an Alternative, Right Parasternal, Electrode Placement (2012) (21)
- Automaticity in the Coronary Sinus (2002) (21)
- Neuropsychological impact of cerebral microemboli in ablation of atrial fibrillation (2015) (21)
- Data on procedural handling and complications of pulmonary vein isolation using the pulmonary vein ablation catheter GOLD®. (2016) (21)
- A new experimentally validated formula to calculate the QT interval in the presence of left bundle branch block holds true in the clinical setting (2017) (20)
- Time-to-isolation-guided cryoballoon ablation reduces oesophageal and mediastinal alterations detected by endoscopic ultrasound: results of the MADE-PVI trial. (2019) (20)
- Spotlight on S-ICD™ therapy: 10 years of clinical experience and innovation. (2019) (20)
- Approach to wide complex tachycardias in patients without structural heart disease (2006) (20)
- The young patient with asymptomatic atrial fibrillation: what is the evidence to leave the arrhythmia untreated? (2014) (19)
- Direct comparison of the novel automated screening tool (AST) versus the manual screening tool (MST) in patients with already implanted subcutaneous ICD. (2018) (19)
- Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry. (2016) (19)
- CHADS2 and CHA2DS2-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus (2013) (19)
- Electrophysiological profile of vernakalant in an experimental whole-heart model: the absence of proarrhythmia despite significant effect on myocardial repolarization. (2014) (19)
- Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes (2020) (18)
- Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent (2017) (18)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. (2020) (17)
- Circumferential pulmonary vein isolation with second-generation multipolar catheter in patients with paroxysmal or persistent atrial fibrillation: Procedural and one-year follow-up results. (2017) (17)
- Pacemaker lead infection and related bacteraemia caused by normal and small colony variant phenotypes of Bacillus licheniformis. (2013) (17)
- Gender Differences in Cardiac Arrhythmias (2005) (17)
- Patients' and procedural characteristics of AV-block during slow pathway modulation for AVNRT-single center 10year experience. (2017) (17)
- Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage (2016) (17)
- Safety profile of multielectrode-phased radiofrequency pulmonary vein ablation catheter and irrigated radiofrequency catheter. (2016) (17)
- Broad antiarrhythmic effect of mexiletine in different arrhythmia models (2018) (17)
- Procedural success, safety and patients satisfaction after second ablation of atrial fibrillation in the elderly: results from the German Ablation Registry (2019) (17)
- The Transcription Factor ATF4 Promotes Expression of Cell Stress Genes and Cardiomyocyte Death in a Cellular Model of Atrial Fibrillation (2018) (17)
- Clinical Value of Electrocardiographic Parameters in Genotyped Individuals with Familial Long QT Syndrome (2001) (17)
- Cardiovascular characterization of Pkd2(+/LacZ) mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2). (2007) (16)
- Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents (2018) (16)
- Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest. (1997) (16)
- Catheter ablation of atrial tachycardia due to recipient-to-donor transatrial conduction after orthotopic heart transplantation. (2004) (16)
- Prolonged QRS Duration Increases QT Dispersion But Does Not Relate to Arrhythmias in Survivors of Acute Myocardial Infarction (2001) (16)
- Pulmonary vein reconnection and arrhythmia progression after antral linear catheter ablation of paroxysmal and persistent atrial fibrillation (2016) (16)
- Late sodium current inhibition: the most promising antiarrhythmic principle in the near future? (2014) (15)
- Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial (2020) (15)
- Prospective evaluation of electrocardiographic parameters in cardiac resynchronization therapy: detecting nonresponders by left ventricular pacing. (2012) (15)
- Ablation Outcomes and Predictors of Mortality Following Catheter Ablation for Ventricular Tachycardia: Data From the German Multicenter Ablation Registry (2018) (15)
- Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer’s Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model (2019) (14)
- Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug? (2017) (14)
- Through modulation of cardiac Ca2+ handling, UCP2 affects cardiac electrophysiology and influences the susceptibility for Ca2+‐mediated arrhythmias (2017) (14)
- Inherited long QT syndrome (2012) (14)
- Dronedarone and digitalis: individually reduced post-repolarization refractoriness enhances life-threatening arrhythmias. (2015) (14)
- Ablation of atrial fibrillation: for whom and how? (2010) (14)
- Antiarrhythmic properties of ivabradine in an experimental model of Short‐QT‐ Syndrome (2017) (14)
- Follow-up of the first patients with a totally subcutaneous ICD in Germany from implantation till battery depletion (2018) (13)
- Triggered activity in atrial myocytes is influenced by Na+/Ca2+ exchanger activity in genetically altered mice. (2016) (13)
- Outcome predictors of empirical slow pathway modulation: clinical and procedural characteristics and long-term follow-up (2015) (13)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population (2020) (13)
- Refinement of detecting atrial fibrillation in stroke patients: results from the TRACK‐AF Study (2018) (13)
- Management of supraventricular arrhythmias in adults with congenital heart disease (2016) (13)
- Prevention of sudden cardiac death in patients with Tetralogy of Fallot: Risk assessment and long term outcome. (2018) (13)
- Vernakalant in an experimental model of pacing-induced heart failure: lack of proarrhythmia despite prolongation of repolarization. (2014) (12)
- Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry (2021) (12)
- Incidence and management of inadvertent puncture and sheath placement in the aorta during attempted transseptal puncture (2016) (12)
- Rationale and design of the MONITOR-ICD study: a randomized comparison of economic and clinical effects of automatic remote MONITORing versus control in patients with Implantable Cardioverter Defibrillators. (2014) (12)
- Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis (2017) (12)
- Routine 18F-FDG PET/CT does not detect inflammation in the left atrium in patients with atrial fibrillation (2017) (12)
- Applicability of a Novel Formula (Bogossian formula) for Evaluation of the QT‐Interval in Heart Failure and Left Bundle Branch Block Due to Right Ventricular Pacing (2017) (12)
- Predictors of long-term success after catheter ablation of atriofascicular accessory pathways. (2012) (12)
- Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study (2022) (12)
- Long-term symptom improvement and patient satisfaction after AV-node ablation vs. pulmonary vein isolation for symptomatic atrial fibrillation: results from the German Ablation Registry (2018) (12)
- Ivabradine Reduces Digitalis‐induced Ventricular Arrhythmias (2017) (11)
- Right versus left parasternal electrode position in the entirely subcutaneous ICD (2018) (11)
- Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone (2017) (11)
- The entirely subcutaneous ICDTM system in patients with congenital heart disease: experience from a large single-centre analysis. (2019) (11)
- Complications and 1-year benefit of cardiac resynchronization therapy in patients over 75 years of age - Insights from the German Device Registry. (2017) (11)
- Long-time “real-life” performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation (2016) (11)
- Antiarrhythmic therapy in heart failure. (2002) (11)
- G-CSF therapy reduces myocardial repolarization reserve in the presence of increased arteriogenesis, angiogenesis and connexin 43 expression in an experimental model of pacing-induced heart failure (2011) (11)
- Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes (2018) (11)
- Colchicine Increases Ventricular Vulnerability in an Experimental Whole‐Heart Model (2017) (11)
- Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry. (2013) (11)
- [The autonomic nervous system and cardiac arrhythmias]. (2002) (10)
- Effect of Sotalol and Acute Ventricular Dilatation on Action Potential Duration and Dispersion of Repolarization After Defibrillation Shocks (2003) (10)
- Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure (2019) (10)
- Is there a prognostic relevance of electrophysiological studies in bundle branch block patients? (2017) (10)
- A patient series of dual atrioventricular nodal nonreentrant tachycardia (DAVNNT) - an often overlooked diagnosis? (2014) (10)
- Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference (2022) (10)
- Extended ECG monitoring with an implantable loop recorder in patients with cryptogenic stroke: time schedule, reasons for explantation and incidental findings (results from the TRACK-AF trial) (2018) (10)
- Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry (2020) (10)
- The Effects of SEA0400 on Ca2+ Transient Amplitude and Proarrhythmia Depend on the Na+/Ca2+ Exchanger Expression Level in Murine Models (2017) (9)
- Machine learning in the detection and management of atrial fibrillation (2022) (9)
- Esophageal and Mediastinal Lesions Following Multielectrode Duty‐Cycled Radiofrequency Pulmonary Vein Isolation: Simple Equals Safe? (2016) (9)
- Right atrial scar detection after catheter ablation: Comparison of 2D and high spatial resolution 3D-late enhancement magnetic resonance imaging. (2011) (9)
- (Tpeak - Tend)/QRS and (Tpeak - Tend)/(QT × QRS) as risk markers in Brugada syndrome: authors' reply. (2017) (9)
- Antiarrhythmic effect of vernakalant in an experimental model of Long-QT-syndrome (2017) (9)
- Feasibility of entirely subcutaneous ICD™ systems in patients with coronary artery disease (2019) (9)
- Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedarone. (2017) (9)
- Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome (2018) (9)
- Inadvertent transseptal puncture into the aortic root: the narrow edge between luck and catastrophe in interventional cardiology. (2019) (9)
- Safety and patient-reported outcomes in index ablation versus repeat ablation in atrial fibrillation: insights from the German Ablation Registry (2020) (9)
- Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial (2022) (9)
- Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T (2020) (8)
- Remaining challenges in catheter ablation of accessory pathways: rare entity of coronary sinus diverticulum-associated pathways (2018) (8)
- Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndrome. (2017) (8)
- Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper'. (2022) (8)
- Lower rate of left atrial tachycardia after pulmonary vein isolation with PVAC versus irrigated-tip circumferential antral ablation. (2016) (8)
- Advantages and limitations of transgenic mice: the role of the Na+/Ca2+ exchanger in cardiac electrophysiology and arrhythmia. (2014) (8)
- Inappropriate shock in a subcutaneous ICD due to interference with a street lantern. (2015) (8)
- A NavX™ Guided Cryoablation of an Accessory Pathway in a Large Coronary Sinus Diverticulum (2005) (8)
- Experimental evidence for a severe proarrhythmic potential of levosimendan. (2017) (8)
- Application of the Bogossian formula for evaluation of the QT interval in pacemaker patients with stimulated left bundle branch block (2018) (8)
- Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis (2020) (8)
- Construction and Interpretation of Endocardial Maps: From Basic Electrophysiology to 3D Mapping (2009) (7)
- Calcium handling and ventricular tachyarrhythmias (2012) (7)
- Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart model. (2017) (7)
- Increased sodium/calcium exchanger activity enhances beta-adrenergic-mediated increase in heart rate: Whole-heart study in a homozygous sodium/calcium exchanger overexpressor mouse model. (2017) (7)
- The role of entirely subcutaneous ICD™ systems in patients with dilated cardiomyopathy. (2019) (7)
- Performance of the entirely subcutaneous ICD in borderline indications (2019) (7)
- Comparing learning curves of two established “single-shot” devices for ablation of atrial fibrillation (2018) (7)
- Clinical, procedural and long-term outcome of ischemic VT ablation in patients with previous anterior versus inferior myocardial infarction (2020) (7)
- The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model (2017) (7)
- [Recommendations of the Working Group of Arrhythmias of the German Society of Cardiology on the approach to patients with Riata® and Riata ST® leads (St. Jude Medical). Nucleus of the Working Group of Arrhythmias of the German Society of Cardiology]. (2012) (7)
- A new algorithm to determine complete isthmus conduction block after radiofrequency catheter ablation for typical atrial flutter. (1999) (7)
- Genetic aspects in acquired long QT syndrome — a piece in the puzzle (2001) (7)
- [AV nodal reentrant tachycardia. Diagnosis and therapy]. (2015) (7)
- Role of the rabbit whole-heart model for electrophysiologic safety pharmacology of non-cardiovascular drugs. (2020) (7)
- Three-dimensional electroanatomic voltage mapping to guide biopsy sampling in unexplained cardiomyopathies: a proof-of-principle case series (2016) (7)
- Device updates successfully reduce T‑wave oversensing and inappropriate shocks in subcutaneous ICD patients (2018) (7)
- Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry (2019) (7)
- [Long QT syndrome and Brugada syndrome. Drugs, ablation or ICD?]. (2005) (7)
- Low proarrhythmic potential of citalopram and escitalopram in contrast to haloperidol in an experimental whole-heart model. (2016) (7)
- The precordial R'-wave: a novel discriminator between cardiac sarcoidosis and arrhythmogenic right ventricular cardiomyopathy in patients presenting with ventricular tachycardia. (2021) (7)
- [Premature ventricular contractions and tachycardia in a structurally normal heart : Idiopathic PVC and VT]. (2019) (6)
- Anterior-posterior vs. anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomized trial☆ (2003) (6)
- Molecular Genetics of the Brugada Syndrome (2007) (6)
- Propofol abolishes torsade de pointes in different models of acquired long QT syndrome (2020) (6)
- Spot diagnosis of inferior axis and concordant R-pattern predicts left ventricular inflow tract tachycardia: Ablation from the great cardiac vein of an underdiagnosed entity. (2016) (6)
- Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy: data from the German device registry (2019) (6)
- Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator? (2006) (6)
- Complex ventricular arrhythmias in patients after heterotopic heart transplantation. (2011) (6)
- Slow pathway modification in patients presenting with only two consecutive AV nodal echo beats. (2017) (6)
- [How to approach the patient with supraventricular tachycardia in the EP lab: A systematic overview]. (2015) (6)
- The ECG in sarcoidosis - a marker of cardiac involvement? Current evidence and clinical implications. (2020) (6)
- In vivo recording of monophasic action potentials in awake dogs – new applications for experimental electrophysiology (2001) (6)
- Effects of genetic background, sex, and age on murine atrial electrophysiology. (2021) (6)
- Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium. (2021) (5)
- Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial. (2022) (5)
- Reduced flow density in patients with atrial fibrillation measured using optical coherence tomography angiography. (2020) (5)
- The long QT syndrome: Considerations in the athletic population (2003) (5)
- Ranolazine Prevents Levosimendan-Induced Atrial Fibrillation (2018) (5)
- AV-Knoten-Reentrytachykardie (2015) (5)
- [AV-reentrant tachycardia and Wolff-Parkinson-White syndrome : Diagnosis and treatment]. (2016) (5)
- Outcomes of ablation in Wolff-Parkinson-White-syndrome: Data from the German Ablation Registry. (2020) (5)
- Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation (2021) (5)
- Shock efficacy of the subcutaneous ICD for prevention of sudden cardiac death: Initial multicenter experience (2013) (5)
- One-Year Course of Periprocedural Anticoagulation in Atrial Fibrillation Ablation: Results of a German Nationwide Survey (2020) (5)
- [Totally subcutaneous cardioverter-defibrillator (S-ICD®) : recent experience and future perspectives]. (2011) (5)
- Real‐Time, Three‐Dimensional, Nonfluoroscopic Localization of the Lasso Catheter (2002) (5)
- Evidence-based treatment of atrial fibrillation around the globe: comparison of the latest ESC, AHA/ACC/HRS, and CCS guidelines on the management of atrial fibrillation. (2022) (5)
- Electrical Alternans In Long QT Syndrome Resembling a Brugada Syndrome Pattern (2003) (5)
- Echocardiography-derived total atrial conduction time (PA-TDI duration): risk stratification and guidance in atrial fibrillation management (2021) (5)
- Prospective blinded evaluation of smartphone-based ECG for differentiation of supraventricular tachycardia from inappropriate sinus tachycardia (2021) (5)
- Arrhythmien aus dem rechten Ventrikel (2004) (5)
- Distinct Occurrence of Proarrhythmic Afterdepolarizations in Atrial Versus Ventricular Cardiomyocytes: Implications for Translational Research on Atrial Arrhythmia (2018) (5)
- Can we rely on Danish? Real-world data on patients with nonischemic cardiomyopathy from the German Device Registry (2019) (5)
- Intracardiac Tuberculoma Causing “Idiopathic” Ventricular Tachycardia in a Patient Without Detectable Heart Disease (2001) (5)
- [High-resolution 3D mapping : Opportunities and limitations of the Rhythmia™ mapping system]. (2018) (5)
- LQT3: who is at risk for sudden cardiac death? (2009) (5)
- Digitalis therapy is associated with higher comorbidities and poorer prognosis in patients undergoing ablation of atrial arrhythmias: data from the German Ablation Registry (2019) (5)
- Improved Clinical Risk Stratification in Patients with Long QT Syndrome? Novel Insights from Multi-Channel ECGs (2016) (5)
- [Right ventricular tachyarrhythmias--diagnostics and therapy]. (2005) (5)
- Acute electrophysiologic effects of the polyphenols resveratrol and piceatannol in rabbit atria (2018) (5)
- Change of sensing vector in the subcutaneous ICD during follow‐up and after device replacement (2018) (5)
- [Current status and problems of the entirely subcutaneous ICD (S-ICD®)]. (2013) (5)
- Long-term single-center experience of defibrillator therapy in children and adolescents. (2018) (5)
- Coronary Artery Calcium as an Independent Surrogate Marker in the Risk Assessment of Patients With Atrial Fibrillation and an Intermediate Pretest Likelihood for Coronary Artery Disease Admitted to a German Chest Pain Unit (2016) (5)
- Response to the letter regarding article, "Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors". (2013) (5)
- [Guideline invasive electrophysiological diagnostics]. (2007) (5)
- Diagnostic and genetic aspects of the Brugada and other inherited arrhythmias syndromes. (2007) (4)
- U Wave during Supraventricular Tachycardia: Simulation of a Long RP Tachycardia and Hiding the Common Type AVNRT (2015) (4)
- Activation of remote monitoring for cardiac implantable electronic devices: small dog for tall weeds (2017) (4)
- Candida tropicalis defibrillator endocarditis: A case report and review of current literature (2019) (4)
- Reduction of inappropriate implantable cardioverter-defibrillator therapies using enhanced supraventricular tachycardia discriminators: the ReduceIT study (2020) (4)
- Antiarrhythmic Effect of Ranolazine in Combination with Selective NCX-Inhibition in an Experimental Model of Atrial Fibrillation (2020) (4)
- Ryanodine‐receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long‐QT syndrome (2018) (4)
- Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated Hearts (2018) (4)
- Influence of Clinical Parameters and Anticoagulation on Intraprocedural Cerebral Microembolic Signals during Pulmonary Vein Isolation (2016) (4)
- Divergent electrophysiologic profile of fluconazole and voriconazole in an experimental whole-heart model of proarrhythmia. (2016) (4)
- Overexpression of the Na+/Ca2+ exchanger influences ouabain‐mediated spontaneous Ca2+ activity but not positive inotropy (2018) (4)
- Torsade de pointes induced by ajmaline (2001) (4)
- Recent advances in the entirely subcutaneous ICD System (2015) (4)
- [Updated ESC guideline: innovations for the treatment of ventricular arrhythmias and recommendations for prevention of sudden cardiac death]. (2016) (4)
- Long-term outcomes after event-free cardioverter defibrillator implantation: comparison between patients discharged within 24 h and routinely hospitalized patients in the German DEVICE registry (2016) (4)
- True Right Bundle Branch Block Masking the Typical ECG in Brugada Syndrome (2005) (4)
- Outcomes after differential use of drug‐eluting stents in diabetic patients: 1‐Year results from the DES.DE (Drug‐Eluting Stent.DEutschland) registry (2010) (4)
- Outcome differences and device performance of the subcutaneous ICD in patients with and without structural heart disease (2019) (4)
- 10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic (2022) (4)
- AB38-3: Impact of programmed ventricular stimulation in patients with Brugada syndrome - a meta-analysis of worldwide published data (2006) (4)
- Therapy of supraventricular and ventricular arrhythmias in adults with congenital heart disease-narrative review. (2021) (3)
- Action Potential Triangulation Explains Acute Proarrhythmic Effect of Aliskiren in a Whole-Heart Model of Atrial Fibrillation (2019) (3)
- Limitations in S-ICD therapy: reasons for system explantation (2015) (3)
- Ventricular Tachycardia and Sudden Cardiac Death (2009) (3)
- Ablation of Atrial Fibrillation in Patients with Hypertension—An Analysis from the German Ablation Registry (2020) (3)
- Accuracy of Deep Learning Echocardiographic View Classification in Patients with Congenital or Structural Heart Disease: Importance of Specific Datasets (2022) (3)
- Postoperative ergometry‐guided programming does not prevent T‐wave oversensing and inappropriate shocks in S‐ICD patients (2018) (3)
- Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft. (2016) (3)
- Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation has no impact on recurrences, cardiovascular events and mortality – insights from the German Ablation Registry (2021) (3)
- Faculty Opinions recommendation of The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. (2015) (3)
- Monday, 27 August 2012 (2012) (3)
- Q Wave in the Inferior Leads: There Is More Than Scar (2015) (3)
- Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia (2016) (3)
- [Early repolarisation. A dilemma of risk stratification]. (2013) (3)
- Heart rate – A complex prognostic marker in acute heart failure (2019) (3)
- Brugada-Syndrom (2020) (3)
- Efficacy and complications of cavo-tricuspid isthmus-dependent atrial flutter ablation in patients with and without structural heart disease: results from the German Ablation Registry (2020) (3)
- Atrial Tachyarrhythmias in Brugada Syndrome (2007) (3)
- Pitfalls of the S-ICD therapy: experiences from a large tertiary centre (2020) (3)
- In vivo recording of monophasic action potentials in awake dogs. (2003) (3)
- In-hospital mortality and major complications related to radiofrequency catheter ablations of over 10 000 supraventricular arrhythmias from 2005 to 2020: individualized case analysis of multicentric administrative data (2022) (3)
- Multielectrode Pulmonary Vein Ablation Catheter (PVAC®) (2014) (3)
- Recurrent Syncope Triggered by Inappropriate Sinus Tachycardia (2004) (3)
- Long-term prognosis of individuals with right predordial ST-elevation - Brugada syndrome (2005) (3)
- [Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications]. (2010) (3)
- Novel surface ECG criteria for differentiation between left- and right-sided manifest inferoseptal accessory pathways. (2009) (3)
- Incidence and predictors of cardiac arrhythmias in patients with COVID-19 induced ARDS (2022) (3)
- Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model (2020) (3)
- Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit Hearts (2020) (2)
- Evaluation of defibrillation safety margin in modern implantable cardioverter defibrillators after administration of amiodarone (2012) (2)
- Detection of Patients with Congenital and Often Concealed Long-QT Syndrome by Novel Deep Learning Models (2022) (2)
- Impella use in real-world cardiogenic shock patients: Sobering outcomes (2021) (2)
- [Indications for implantable loop recorders in patients with channelopathies and ventricular tachycardias]. (2016) (2)
- [Current status of cardiac electrophysiology training in Germany]. (2020) (2)
- Impact of diabetes on clinical outcome of patients with heart failure undergoing ICD and CRT procedures: results from the German Device Registry (2020) (2)
- Predictors of AVNRT Recurrence After Slow Pathway Modification. (2021) (2)
- Diagnosis and management of cold urticaria in cryoablation of atrial fibrillation: a case report (2019) (2)
- Determinants of inappropriate implantable cardioverter-defibrillator shocks: the German Device Registry perspective (2019) (2)
- Ocular perfusion in patients with reduced left ventricular ejection fraction measured by optical coherence tomography angiography (2021) (2)
- [Arrhythmia in adults with congenital heart defects : Incidence, substrates, and mechanisms]. (2016) (2)
- [New concepts in the therapy of atrial fibrillation]. (2011) (2)
- Expect the (un)expected: a hazardous cause of tako-tsubo cardiomyopathy. (2014) (2)
- Comparison of vernakalant and ranolazine in atrial fibrillation (2017) (2)
- 101 – Drug-Induced Ventricular Tachycardia (2014) (2)
- Cardiovascular risk of energy drinks: Caffeine and taurine facilitate ventricular arrhythmias in a sensitive whole‐heart model (2022) (2)
- MRI of right atrial function after catheter ablation of atrial flutter. (2010) (2)
- Simultaneous in utero assessment of AV nodal and ventricular electrophysiologic parameters in the fetal sheep heart (2001) (2)
- [The ICD as primary prevention. Rare indications]. (2010) (2)
- Quantifying Left Atrial Size in the Context of Atrial Fibrillation Ablation: Which Echocardiographic Method Correlates to Outcome of Pulmonary Venous Isolation? (2021) (2)
- Quinolones and proarrhythmia: Differgent torsadogenic potential despite similar effects on myocardial repolarizaiton (2005) (2)
- Giant right ventricular metastasis of hypopharyngeal cancer complicated by ventricular tachycardia and cardiogenic shock. (2014) (2)
- Early mortality in implantable cardioverter defibrillator patients: from randomized controlled trials to real life. (2009) (2)
- Cardiac computed tomography in patients with symptomatic new-onset atrial fibrillation, rule-out acute coronary syndrome, but with intermediate pretest probability for coronary artery disease admitted to a chest pain unit (2018) (2)
- Thyroid Dysfunction under Amiodarone in Patients with and without Congenital Heart Disease: Results of a Nationwide Analysis (2022) (2)
- [Clinical aspects and molecular genetics of the Jervell- and Lange-Nielsen Syndrome]. (2002) (2)
- T peak – T end interval and T peak – T end /QT ratio in patients with Brugada syndrome (2016) (2)
- Cardiovascular Magnetic Resonance-Guided Radiofrequency Ablation: Where Are We Now? (2022) (2)
- The Incidence, Electrophysiological Characteristics and Ablation Outcome of Left Atrial Tachycardias after Pulmonary Vein Isolation Using Three Different Ablation Technologies (2022) (2)
- [Innovations in invasive electrophysiology : What awaits us?] (2020) (1)
- Sensitive Detection of Atrial Fibrillation in Acute Stroke Patients by Short-Term Bedside Electrocardiography Monitoring Software Analysis (2018) (1)
- Proarrhythmic potential of metoclopramide in a sensitive whole‐heart model (2021) (1)
- [Brugada syndrome. Current clinical aspects and risk stratification]. (2002) (1)
- Role of Body Surface Mapping (2009) (1)
- A case of 'tiger heart': a distinct variant of left ventricular non-compaction. (2020) (1)
- [Cardiac arrhythmias in patients with chronic kidney disease]. (2019) (1)
- Faculty Opinions recommendation of Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction. (2015) (1)
- Supraventricular extrasystole due to 1:2 atrioventricular conduction: procedural characteristics and long term follow-up of slow pathway modulation (2013) (1)
- History of Cardiac Mapping (2019) (1)
- Cardiac Arrhythmias in Survivors of Sudden Cardiac Death Requiring Impella Assist Device Therapy (2021) (1)
- Transmural dispersion in LQT 3 and arrhythmogenesis (2005) (1)
- 1012No support for additional left atrial substrate modification among patients with persistent atrial fibrillation at first PVI procedure- Results from German Ablation registry (2018) (1)
- Haemodynamic Alterations Induced By Cardiac Pacing: Is Clinical Evaluation Sufficient Or Do We Need Long-Term Device Monitoring? (2015) (1)
- Atrioventricular nodal re-entrant tachycardia in a patient with Ebstein anomaly (2004) (1)
- Incidence and predictors of left atrial appendage thrombus on transesophageal echocardiography before elective cardioversion (2021) (1)
- Safe electrophysiologic profile of dexmedetomidine in different experimental arrhythmia models (2021) (1)
- [From premature ventricular complexes to sustained ventricular tachycardia : An overview of innovations in the 2022 ESC Guideline on the therapy of ventricular arrhythmias]. (2022) (1)
- PROGRESSION OF PAROXYSMAL TO PERSISTENT AF IN PATIENTS AWAITING AF ABLATION (2015) (1)
- The impact of basic atrial rhythm during catheter ablation of atrial fibrillation on clinical outcomes: Lessons from the German Ablation Registry (2021) (1)
- Atrial Flutter in a Patient with Postoperative AV Block and Right Infero‐Septal Accessory Pathway: How to Preserve AV Conduction (2012) (1)
- Outcomes in patients experiencing complications associated with atrial fibrillation ablation: Data from the German ablation registry. (2022) (1)
- Tuesday, 28 August 2012 (2012) (1)
- Outcome of patients with idiopathic ventricular fibrillation and correlation with ECG markers of early repolarization. (2022) (1)
- 102-04: Performance and Outcomes in Patients with the Subcutaneous Implantable Defibrillator Through Mid Term Follow-Up: The EFFORTLESS Study (2016) (1)
- Pulmonary Vein Isolation in Obese Compared to Non-Obese Patients: Real-Life Experience from a Large Tertiary Center (2022) (1)
- Current Indications for the Implantable Cardioverter Defibrillator (2004) (1)
- Current Indications for ICD Therapy (2004) (1)
- Occurrence of primarily noninducible atrioventricular nodal reentry tachycardia after radiofrequency delivery in the slow pathway region during empirical slow pathway modulation (2017) (1)
- Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial (2021) (1)
- Suppression of Early and Late Afterdepolarizations by Heterozygous Knockout of the Na + / Ca 2 + Exchanger in a Murine Model Running title : (2015) (1)
- Benefits of early rhythm control of atrial fibrillation. (2023) (1)
- A Case of Paroxysmal Supraventricular Tachycardia (2004) (1)
- Drug Challenge in Brugada Syndrome: How Valuable Is It? (2006) (1)
- Predictors of response to cardiac resynchronization therapy in patients with chronic right ventricular pacing (2020) (1)
- Innovationen in der invasiven Elektrophysiologie (2020) (1)
- Loss of the tip of a transseptal needle in the heart. (2011) (1)
- [Cardiac arrhythmias in pregnancy : Epidemiology, clinical characteristics, and treatment options]. (2021) (1)
- [Atrial fibrillation in patients with sepsis and non-cardiac infections]. (2019) (1)
- [Atrial fibrillation: molecular biology bases]. (2002) (1)
- Selection and outcome of implantable cardioverter‐defibrillator patients with and without cardiac resynchronization therapy: Comparison of 4384 patients from the German Device Registry to randomized controlled trials (2022) (1)
- Transmural dispersion in LQT3 and arrhythmogenesis (2005) (1)
- Slow pathway modulation in a patient with tricuspid valve atresia (2013) (1)
- Very Long-Term Follow-Up in Cardiac Resynchronization Therapy: Wider Paced QRS Equals Worse Prognosis (2021) (1)
- Ablation of paroxysmal and persistent atrial fibrillation in the very elderly real‐world data on safety and efficacy (2020) (1)
- Five year outcomes of the subcutaneous implantable cardioverter-defibrillator EFFORTLESS (evaluation of factors impacting clinical outcome and cost effectiveness of the S-ICD) registry (2021) (1)
- Deactivation of implanted cardioverter-defibrillators at the end of life in the setting of an outpatient clinic. (2012) (1)
- Pulmonary vein isolation in the presence of an interatrial shunt device. (2020) (1)
- Cardiac glycosides are not associated with increased mortality or hospitalization rates in ICD and CRT-ICD patients after adjustment for baseline-characteristics at one-year follow-up: Results from the German DEVICE registry. (2021) (1)
- The Impact of Cardiac Devices on Patients’ Quality of Life—A Systematic Review and Meta-Analysis (2022) (1)
- [Syncope of unknown origin in heart failure: which diagnostic possibilities should be considered today?]. (2001) (1)
- A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study. (2023) (1)
- Management of Ventricular Arrhythmias Worldwide (2023) (1)
- Erratum: Sodium channel gene (SCN5A) mutations in 44 index patients with brugada syndrome: Different incidences in familial and sporadic disease (2005) (1)
- Improvement of Retinal Microcirculation after Pulmonary Vein Isolation in Patients with Atrial Fibrillation—An Optical Coherence Tomography Angiography Study (2021) (1)
- Single beta-blocker or combined amiodarone therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy defibrillator patients - insights from the German DEVICE-registry. (2022) (1)
- Protective effects of thoracic epidural anesthesia on arrhythmogenesis in awake chronically instrumented dogs (1998) (1)
- [The new ESC guidelines on the management of ventricular tachyarrhythmias : Implications for daily practice]. (2022) (1)
- Idiopathic left ventricular tachycardia localised at the distal end of the posterior fascicle by non-contact activation mapping (2002) (1)
- [Management of premature ventricular ectopy in cardiac resynchronization therapy : Treatment strategies for an optimized cardiac resynchronization]. (2021) (1)
- [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis]. (2008) (1)
- Bullet-associated ventricular tachycardia: a case report (2021) (1)
- Editorial (Thematic Issue: Experimental Pharmacological Targets for the Treatment of Cardiac Arrhythmias: Beyond the Vaughn-Williams Classification) (2014) (1)
- Electrophysiology lab efficiency comparison between cryoballoon and point-by-point radiofrequency ablation: a German sub-analysis of the FREEZE Cohort study (2023) (1)
- Outcome of slow pathway modulation for atrioventricular nodal reentrant tachycardia with 50 versus 30 watts—more power, more effect? (2018) (1)
- Monitoring the decay of the current of injury (COI): A re-visited parameter to predict performance of transvenous pacemaker leads. (2018) (1)
- [Treatment of ventricular tachyarrhythmias and prevention of sudden cardiac death: commentary on the 2016 ESC guideline]. (2016) (0)
- Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome (2018) (0)
- 776 Incidence and Clinical Significance of Atrial Fibrillation under Mechanical Circulatory Support Systems. Role of Catheter Ablation (2012) (0)
- AB33-1: Clinical aspects of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome (2006) (0)
- [Arrhythmias in heart insufficiency]. (2000) (0)
- High-Density Mapping Revealing Figure-of-Eight Re-entrant Atrial Tachycardia in Uhl's Anomaly. (2021) (0)
- Background of ICD Therapy (2004) (0)
- Reproducible Conversion from Wide to Narrow Complex Tachycardia: (2000) (0)
- Underlying mechanisms of life threatening interactions of a combination therapy with dronedarone and digitalis (2013) (0)
- Calcium is omnipresent in the physiology and pathophysiology of heart disease (2012) (0)
- 366No support for additional left atrial substrate modification among patients with persistent atrial fibrillation at first PVI procedure - results from German Ablation registry (2018) (0)
- P1063Activation of remote monitoring for cardiac implantable electronic devices: small dog, tall weeds (2017) (0)
- 275 Long-term prognosis of individuals with right precordial ST-elevation — Brugada syndrome (2005) (0)
- [Anticoagulation in high thromboembolic risk after catheter ablation for atrial fibrillation: results from the German Ablation Registry]. (2014) (0)
- [New knowledge in arrhythmogenesis--role of ion channels and genetic aspects]. (2000) (0)
- P2694Divergent antiarrhythmic effects of the polyphenols resveratrol and piceatannol in an experimental whole-heart model of long QT syndrome (2017) (0)
- Predictors for progression of atrial fibrillation in patients awaiting AF ablation (2016) (0)
- Detection of cerebral microbleeds in patients treated with oral anticoagulants (2008) (0)
- Empirical slow pathway modulation: clinical and procedural characteristics as well as long term follow-up (2013) (0)
- Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit Hearts (2020) (0)
- [3-D mapping and ablation of recurrent ventricular tachycardia in patients with ischemic cardiomyopathy]. (2017) (0)
- 1272Effect of age, genetic background and experimental conditions on left atrial monophasic action potential duration, effective refractory period and activation time in Langendorff-perfused murine hearts (2020) (0)
- Beneficial electrophysiologic effects of sacubitril in different arrhythmia syndromes (2020) (0)
- Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure (2019) (0)
- Dexmedetomidine reduces ventricular arrhythmias in a model of drug-induced QT-prolongation (2020) (0)
- Reply to letter to the editor by Gulmira Kudaibedieva and Bulent Gorenek (2019) (0)
- [Electromagnetic interference in 3D-mapping procedures]. (2022) (0)
- [Complications associated with catheter ablation of atrial fibrillation]. (2014) (0)
- [Cardiovascular function and anemia. Using caution in patients with established cardiac diseases]. (1999) (0)
- Antiarrhythmic effect of Vernakalant due to reduction of dispersion of repolarization and suppression of early afterdepolarizations in a rabbit model of acquired long-QT-syndrome (2013) (0)
- 375 Radiofrequency ablation of idiopathic ventricular ectopy in comparison to sustained idiopathic ventricular tachyarrhythmias using noncontact activation mapping (2005) (0)
- [Not Available]. (2015) (0)
- 1075Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator. Less is more. Data from the German Device Registry (2018) (0)
- Resolution of left atrial appendage thrombi: No difference between phenprocoumon and non‐vitamin K‐dependent oral antagonists (2022) (0)
- The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model (2017) (0)
- Smartphone-based ECG devices: Beyond atrial fibrillation screening. (2021) (0)
- Safe electrophysiologic profile of the neprilysin-inhibitor sacubitril in combination with different antiarrhythmic drugs (2022) (0)
- Abstract 1094: Transcription Signature of Ion Channel Genes in Brugada Syndrome (2006) (0)
- Arrhythmogenesis in cardiac hypertrophy andheart failure - experimental findings (2008) (0)
- [Atrial and ventricular premature contractions-the "wolf in sheep's clothing"? : What is new, what is important, what to do?] (2021) (0)
- [ICD programming : multicenter automatic defibrillator implantation trial - reduce inappropriate therapy (MADIT-RIT)]. (2013) (0)
- Distribution and impact of age in patients with implantable cardioverter-defibrillators regarding early complications and 1-year clinical outcome: results from the German Device Registry (2020) (0)
- Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated Hearts (2018) (0)
- Faculty Opinions recommendation of Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. (2015) (0)
- Long-term experience of atrioventricular node ablation in patients with refractory atrial arrhythmias (2019) (0)
- Narrative review of: risk stratification and implantable cardioverter-defibrillator therapy in adults with congenital heart disease. (2021) (0)
- 752 Kidney disease in patients with chronic heart failure ‐ impact on intracardiac conduction, diastolic function and prognosis (2006) (0)
- Antithrombotic treatment strategies after PCI – Authors' reply (2020) (0)
- [Right ventricular arrhythmias]. (2004) (0)
- A real-time tip manometer for radiofrequency catheter ablation: new toy or useful tool? (2011) (0)
- A single-center experience in transvenous coronary sinus lead extraction and re-implantation. Technical issues and alternative re-implantation approaches (2013) (0)
- Abstract 16513: Very Long-Term Follow-up in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and an Implantable Cardioverter/Defibrillator (2010) (0)
- Symptomatic arrhythmias after catheter ablation of atrioventricular nodal reentrant tachycardia (AVNRT): results from the German Ablation Registry (2019) (0)
- Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation—Insights from the German Ablation Registry (2021) (0)
- P2686Antiarrhythmic effect of the anti-influenza drug oseltamivir in an experimental whole-heart model of atrial fibrillation (2017) (0)
- Mapping of Ventricular Tachycardias in Rare Cardiomyopathies (2012) (0)
- [Life-threatening cardiac arrhythmias]. (2021) (0)
- Legal Implications of Defibrillator Guidelines (2004) (0)
- Incidence and Predictors of Left Atrial Appendage Thrombus before Catheter Ablation of Thrombogenic Arrhythmias (2022) (0)
- Early Mortality After VT Ablation (2023) (0)
- Thinking about the future – data on adolescent patients with a subcutaneous ICD (2020) (0)
- Pharmacology of myocardial calcium-handling (2012) (0)
- Psychological Aspects of Syncopes and Possible Association with Recurrency—The Role of Implantable Loop Recorders (2022) (0)
- Predicting inappropriate S-ICD® episodes by simple 12-lead surface ECG parameters. (2021) (0)
- Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation—A Prospective 123I-mIBG-SPECT/CT Imaging Study (2021) (0)
- Usefulness of the MADIT-ICD Benefit Score in a S-ICD Patient Cohort (2021) (0)
- Edoxaban in atrial fibrillation with PCI by ACS or stable CAD presentation: a pre-specified analysis of the ENTRUST-AF PCI trial (2020) (0)
- Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia (2016) (0)
- Divergent electrophysiologic safety profile of dapagliflozin and empagliflozin in a whole-heart model (2022) (0)
- Driving with a drive-line: an evidence based approach of driving restriction after implantation of left ventricular assist device in end stage heart failure (2014) (0)
- [Subcutaneous implantable cardioverter-defibrillator : Current status and perspectives]. (2018) (0)
- [Atrial fibrillation : new anticoagulants and antiarrhythmic drugs]. (2012) (0)
- Outcome of catheter ablation in the very elderly‐insights from a large matched analysis (2020) (0)
- Editorial: experimental pharmacological targets for the treatment of cardiac arrhythmias: beyond the Vaughn-Williams classification. (2014) (0)
- Komplikationsmanagement in der invasiven Elektrophysiologie (2015) (0)
- OP-EHEA190744 1..11 (2019) (0)
- Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model (2020) (0)
- Letter by Müller et al Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source". (2019) (0)
- Considering Ranolazine as a Potential Treatment for K+ Channel Linked Short QT Syndrome (2016) (0)
- [Catheter ablation of electrical storm: ready for prime time?]. (2014) (0)
- Increased in vivo perpetuation of whole-heart ventricular arrhythmia in heterozygous Na+/Ca2+ exchanger knockout mice (2019) (0)
- Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer’s Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model (2019) (0)
- Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone (2017) (0)
- WITHDRAWN: Safety of Multielectrode Phased Radiofrequency Pulmonary Vein Ablation Catheter and Irrigated Radiofrequency Catheter (2014) (0)
- [Catheter ablation of atrial fibrillation 2014: current status and outlook]. (2014) (0)
- Dapagliflozin but not empagliflozin prevents atrial fibrillation in an experimental whole-heart model (2022) (0)
- [ECG changes in primary neurological disorders, systemic diseases and primary cardioymopathies]. (2013) (0)
- Electrophysiology APPROACH TO WIDE COMPLEX TACHYCARDIAS IN PATIENTS WITHOUT STRUCTURAL HEART DISEASE (2006) (0)
- P5779Long-term single-center experience of transvenous defibrillator therapy in children and adolescents (2018) (0)
- Wednesday, 29 August 2012 (2012) (0)
- P788Antazoline suppresses torsade de pointes in a whole-heart model of long QT syndrome (2017) (0)
- Action Potential Triangulation Explains Acute Proarrhythmic Effect of Aliskiren in a Whole-Heart Model of Atrial Fibrillation (2019) (0)
- Pulmonary vein isolation in patients with paroxysmal atrial fibrillation is associated with regional defects in cardiac sympathetic activity (2012) (0)
- The esophagus and the left atrium: Anatomical implications for radiofrequency ablation of atrial fibrillation (2005) (0)
- 793 Electrocardiographic risk stratification in genotyped patients with congenital long QT-syndrome (2005) (0)
- P783Influencing factors of in-hospital pacemaker implantation after ablation of AV-nodal reentry- and AV-reentry tachycardia: results from the German ablation registry (2017) (0)
- Nonischemic Dilated Cardiomyopathy (2012) (0)
- ESC-Leitlinie 2020 zum Vorho ffl immern: Was ist neu, was ist wichtig, was ist zu tun? ESC guideline 2020 on atrial fibrillation: What's new, what's important, what to do? (2021) (0)
- P1695Mexiletine suppresses torsade de pointes in a whole-heart model of long QT syndrome (2017) (0)
- Bradycardia in Patients with Subcutaneous Implantable Defibrillators—An Overestimated Problem? Experience from a Large Tertiary Centre and a Review of the Literature (2022) (0)
- Current clinical aspects and risk stratification n Summary Brugada syndrome (2002) (0)
- Selection and outcome of ICD and CRT-D patients - Comparison of 4384 patients from the German Device Registry to randomized controlled trials. (2022) (0)
- Evolution of Guidelines for Defibrillator Therapy (2004) (0)
- P6591Arrhythmogenic effects of non-steroidal anti-inflammatory drugs (NSAID) (2019) (0)
- Dronedarone-mediated antiarrhythmic but not inotropic effects depend on Na+/Ca2+ exchanger (NCX) activity: Investigations in NCX knockout and overexpressor mice (2013) (0)
- 4102Relation between serum values of angiopoietin-2 and vascular endothelial growth factor with the degree of cardiomyopathy and skeletal myopathy in patients with muscular dystrophy (2017) (0)
- University of Birmingham Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (2020) (0)
- [New developments in leadless pacing systems]. (2021) (0)
- Incidence of left atrial appendage thrombus on pre-procedural TOE before catheter ablation of atrial tachyarrhythmias (2021) (0)
- P1905Propofol suppresses atrial fibrillation in an experimental whole-heart model (2019) (0)
- P2672Which factors are associated with acute pacemaker implantation after ablation of atrial fibrillation (2017) (0)
- [Managing complications in invasive electrophysiology]. (2015) (0)
- P988Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy - data from the German device Registry (2019) (0)
- Usefulness of the MADIT-ICD Benefit Score in a Large Mixed Patient Cohort of Primary Prevention of Sudden Cardiac Death (2022) (0)
- Experimental evidence for proarrhythmic effects of nonsteroidal anti‐inflammatory drugs in a sensitive whole‐heart model (2021) (0)
- [Catheter ablation of ventricular arrhythmias. Complications and emergency situations]. (2015) (0)
- P3190 Circumferential pulmonary vein ablation guided by real-time, three-dimensional non-fluoroscopic localization of the Lasso catheter (2003) (0)
- P2869Electrophysiologic profile of propofol in isolated rabbit hearts (2018) (0)
- P2871Aliskiren promotes atrial fibrillation in an experimental whole-heart model (2018) (0)
- P6404Antazoline prevents ventricular arrhythmias in an experimental model of short QT syndrome (2017) (0)
- Idiopathic Ventricular Fibrillation – How to Treat? (2016) (0)
- Outcome of catheter ablation of supraventricular tachyarrhythmias in cardiac sarcoidosis (2019) (0)
- Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects. (2023) (0)
- Faculty Opinions recommendation of Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. (2015) (0)
- Electrophysiological Safety Profile of Antiestrogenic Therapies in the Isolated Rabbit Heart (2022) (0)
- B-PO 01-005 ACUTE PROARRHYTHMIC EFFECT OF ANTI-ACETYLCHOLINEESTERASE DRUGS USED IN THE TREATMENT OF DEMENTIA : BENEFIT OF RIVASTIGMINE (2018) (0)
- Faculty Opinions recommendation of Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. (2015) (0)
- Patient With Presyncope and Variable PR Interval and QRS Morphology (2021) (0)
- [Typical atrial flutter: Diagnosis and therapy]. (2016) (0)
- Mediastinal and esophageal injuries following radiofrequency ablation of atrial fibrillation (2009) (0)
- Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents (2017) (0)
- Mechanisms of Antifibrillatory Agents for Atrial Fibrillation (2019) (0)
- 284 Where is the esophagus? Anatomical implications for ablation of atrial fibrillation (2005) (0)
- Autonomic dysfunction in Brugada syndrome New evidence for enhanced presynaptic norepinephrine recycling and subsequent reduction of adrenergic myocardial stimulation (2003) (0)
- ECG risk stratification in genotyped patients with congenital long QT-syndrome (2005) (0)
- Comments on the 2015 ESC guidelines on ventricular arrhythmia and prevention of sudden cardiac death (2017) (0)
- Electrophysiologic effects of sacubitril in different arrhythmia models. (2022) (0)
- Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly—results of a retrospective multi-center study (2023) (0)
- [Anatomy of the left ventricle for endocardial ablation]. (2022) (0)
- Listen to Your Heart: Evaluation of the Cardiologic Ecosystem (2021) (0)
- Reply to Letter to the Editor Transmural dispersion in LQT 3 and arrhythmogenesis (2005) (0)
- Response to the letter regarding article "A patient series of dual atrioventricular nodal nonreentrant tachycardia (DAVNNT)--an often overlooked diagnosis?". (2014) (0)
- [The ECG -- beyond the "big" issues]. (2013) (0)
- Faculty Opinions recommendation of How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? (2015) (0)
- 929 Electrode type matters for external cardioversion of atrial fibrillation: the MOBIPAPA trial (2005) (0)
- P342Time-to-isolation-guided cryoballoon pulmonary vein isolation reduces esophageal and mediastinal alterations detected by endoscopic ultrasound (2019) (0)
- Antiarrhythmic therapy of atrial fibrillation: are we treating too late? (2014) (0)
- Genetic background, sex, age and pacing cycle length affect left atrial electrophysiology in Langendorff-perfused isolated murine hearts (2020) (0)
- Clinical Research Predictors for Progression of Atrial Fibrillation in Patients Awaiting Atrial Fibrillation Ablation (2016) (0)
- [ESC guideline 2022: management of ventricular arrhythmias in clinical practice]. (2023) (0)
- Improved risk stratification for patients with atrial fibrillation by advancing the concept of atrial cardiomyopathy? (2018) (0)
- Improving outcomes with bivalirudin in primary percutaneous coronary intervention (2014) (0)
- Is it possible to prevent sudden death? – primary prevention (2006) (0)
- Abstracts: Basic Science in arrhythmias: mechanisms (2009) (0)
- Lyme carditis manifesting with sinoatrial exit block: a case report (2022) (0)
- P2868Ranolazine reduces levosimendan-mediated atrial fibrillation in an experimental whole-heart model (2018) (0)
- P786Factors associated with acute pacemaker implantation after carvo- tricuspidal isthmus ablation - results from the German ablation registry (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With L. E. Eckardt?
L. E. Eckardt is affiliated with the following schools:
